In its projection, the Indian Council of Medical Research (ICMR) said in 2016 the total number of new cancer cases is expected to be around 14.5 lakh and the figure is likely to reach nearly 17.3 lakh new cases in 2020.
Over 7.36 lakh people are expected to succumb to the disease in 2016 while the figure is estimated to shoot up to 8.8 lakh by 2020. Data also revealed that only 12.5 per cent of patients come for treatment in early stages of the disease.
The northeast reported the highest number of cancer cases in both males and females. Aizawl district in Mizoram reported the highest number of cases among males while Papumpare district in Arunachal Pradesh recorded the highest number among females.
"Cancer of breast with estimated 1.5 lakh (over 10 per cent of all cancers) new cases during 2016, is the number one cancer overall. Cancer of the lung is the next with estimated 1.14 lakh (83,000 in males and 31,000 in females) new cases during 2016 and 1.4 lakh cases in 2020.
The ICMR also conducted a country-wide study from 2012-14 from various Population Based Cancer Registeries (PBCR) and Hospital Based Registeries.
It also stated there was a "significant" increase in cancers of rectum and colon in males in the PBCRs at Bangalore, Chennai, and Delhi and in females in Barshi and Bhopal.
Among males, there was also a significant increase in the cases of cancers of colon, rectum and prostate in Bengalore, Chennai and Delhi while among women there was a significant increase in the rate of cancers related to breast, uterus, ovary and lung.
Among males, mouth cancer is leading in registry areas of the western states of the country while among the females of East Khasi hills in Meghalaya recorded the highest number of cases of mouth cancer among women.
(REOPENS DEL57)
Nandkumar said there was a rise in cases of lung cancer
among females because more and more women are taking up smoking.
The study also revealed a rise in the number of cases of gall bladder cancer in the Gangetic belt.
ICMR has also demanded that cancer be declared a "notifiable disease" like HIV and tuberculosis as this will help in better monitoring of the patients.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
